The U.S. stock market seems risky now because valuations are rich, as sentiment marches higher. But there’s a fix for that: load up on disliked, cheap value stocks. By many measures, value stocks are lagging growth stocks by almost as much as they ever have in the past several decades. UsuallyRead More →
Earnings at big U.S. banks, scheduled for next week, will show mixed results, as lower interest rates offset higher trading revenue. J.P. Morgan Chase & Co. JPM, -1.00% and Wells Fargo & Co. WFC, -0.44% on Jan. 14 will be first to release fourth-quarter results. When the Federal Reserve reversedRead More →
Technology stocks have had an amazing ride. But some, including Netflix and Twitter, are less expensive relative to earnings estimates than they were a year ago. You are no doubt aware that 2019 was an excellent year for U.S. stocks. Still, a breakdown of the 11 sectors of the S&PRead More →
To celebrate the new year, here are some of the most popular MarketWatch articles of 2019. The one with the most readers by far was Catey Hill’s interview with a retired teacher who moved to Panama and believes it would be “an act of insanity to stay in the U.S.”Read More →
Shares of Flexion Therapeutics Inc. soared 14% Friday, after the company said the U.S. Food and Drug Administration has approved an update to the label on its Zilretta treatment for osteoarthritis (OA) knee pain that analysts said should help it get reimbursement from insurers and boost sales. Burlington, Mass.-based FlexionRead More →
This has been an excellent year for U.S. stocks — so good, in fact, that among the S&P 500, only 57 have had negative returns. But it may be profitable to look among the losers for bargains. Mark Hulbert recently pointed to a trend among stocks in the Dow JonesRead More →
Health care is expected to be one of the most important issues in the coming 2020 presidential election, which could lead to a bumpy year for investors, but don’t expect to see any dramatic changes to the U.S. health care system anytime soon. The nation’s largest drugmakers, pharmacy benefit managersRead More →
U.S. stocks with attractive dividend yields have performed very well this year, for obvious reasons: Interest rates have declined at home and investors in Europe and Japan — where government and central-bank policies have pushed bond yields well into the negative — are desperate to find investments that will giveRead More →
United Parcel Services Inc. stock slid Wednesday, after BMO downgraded the stock and said the rise of e-commerce is disrupting the delivery business as more parcels go to residential addresses than businesses, squeezing profit for the incumbents. UPS shares UPS, -0.19% were down 1.4% in afternoon trade, bringing their month-to-dateRead More →
Cannabis stocks fell for a third straight day Monday, weighed down by the industry’s continued weak fundamentals with companies still posting losses as they struggle to generate revenue. The market is digesting the final third-quarter numbers from Canadian and U.S. players and sentiment is being hurt by weaker-than-expected results, accordingRead More →
Roku Inc.’s stock surged more than 400% through the first 11 months of the year, and Morgan Stanley analyst Benjamin Swinburne is concerned that it’s about to head in reverse. Swinburne downgraded Roku shares ROKU, -15.91% to underweight from equal-weight on Monday, writing that the stock looks far too expensive,Read More →
Cannabis stocks were mostly lower Monday, with Aurora Cannabis slumping after the company carried out a convertible debt swap that is highly dilutive for its shareholders. Aurora stock ACB, -5.93% ACB, -4.89% fell 3.7% after it set the early conversion price for C$230 million ($173 million) of 5% convertible bondsRead More →
Cannabis stocks ended their three-day winning streak on Friday, as the euphoria sparked by a House vote in favor of a bill that would lift the U.S. federal ban eased and investors refocused on the sector’s weak fundamentals. The bill, introduced by House Judiciary Committee Chairman Jerrold Nadler, a NewRead More →
Cannabis stocks rallied across the board Thursday, as investors returned to the beaten-down-sector with a fresh enthusiasm, following a historic House vote in favor of a bill that would lift the federal ban on weed. The three biggest Canadian licensed producers – Canopy Growth, Cronos Group and Aurora Cannabis –Read More →
Intel Corp.’s apology Wednesday to customers about its ongoing supply constraints did not appear to surprise investors, but the news could prove to be an eventual benefit to rival Advanced Micro Devices Inc. Earlier on Wednesday, the chip giant gave customers an update in a regulatory filing about its currentRead More →
Cannabis stocks were a sea of red again on Monday, with Aurora Cannabis tumbling another 9% following disappointing earnings and MedMen down 17% on news of job cuts and asset sales. The ETFMG Alternative Harvest ETF MJ, -3.48% was last down 2.3% with 23 of its 36 member stocks tradingRead More →
The U.S. stock market will fight strong headwinds in the months leading to Election Day in November 2020. But the fear that’s transfixing investors on both sides will turn to relief for supporters of the winning party once the outcome is known. At that point the headwind will quickly shiftRead More →
Shares of Chesapeake Energy Corp. broke the buck Wednesday for the first time in over 20 years, as the oil and natural gas company’s “going concern” warning rattled Wall Street. The stock CHK, -0.70% plummeted 29.2% to 91 cents, after tumbling 18.0% to $1.28 on Tuesday in the wake ofRead More →
On Wall Street, rose-colored glasses come with the territory. The Dow Jones Industrial Average DJIA, +0.02% and the Standard & Poor’s 500 SPX, +0.26% both just hit all-time highs after one of the quietest, most grudging rallies I’ve ever seen. Yet the latest meme circulating down in the Canyon ofRead More →
Let’s go back in time to June 2008, when Apple introduced the iPhone 3G. Nokia then was the world’s largest phone maker. What we did not know at the time was that Nokia was actually the largest dumb phone maker and that Apple was about to become the largest smartphoneRead More →
J.P. Morgan has been one of the more aggressive Wall Street shops on stocks for some time, and it is reiterating its overweight call on equities and commodities and underweight on bonds. What’s new is that it’s reversing an overweight in gold to a small underweight, as well as shiftingRead More →
“When we try to pick out anything by itself, we find it hitched to everything else in the universe,” wrote famed naturalist John Muir more than a century ago, referring to an epiphany he had while hiking in California’s Yosemite Valley. In our call of the day, Blackstone BX, +1.88%Read More →
Catey Hill helps MarketWatch readers find retirement destinations that fit their specific wish lists. Most are looking for cheaper places to live. But now a reader with a net worth of $5 million wants someplace that isn’t stiflingly hot, has good health care and isn’t in California. She offered threeRead More →
After several similar doom-and-gloom warnings in the past, one analyst isn’t too bothered by Facebook Inc.’s latest talk of steep cost growth down the road. The company told investors in conjunction with its late-Wednesday earnings report that it expects $46 billion to $48 billion in total expenses for 2019, thoughRead More →
Tesla Inc. shares continued their late-session rally Thursday, as some analysts weighing in on its third-quarter surprise profit waxed lyrical in their evaluation of the numbers. Wedbush bull Daniel Ives said the Silicon Valley electric car maker TSLA, +14.95% had delivered a “Picasso-like quarter” which was potentially “game changing” withRead More →